Your browser doesn't support javascript.
loading
Incidence of cardiovascular events and risk markers in a prospective study of children diagnosed with Marfan syndrome.
Hascoet, Sebastien; Edouard, Thomas; Plaisancie, Julie; Arnoult, Florence; Milleron, Olivier; Stheneur, Chantal; Chevallier, Bertrand; Zordan, Cécile; Odent, Sylvie; Bal, Laurence; Faivre, Laurence; Leheup, Bruno; Dupuis-Girod, Sophie; Ruidavets, Jean-Bernard; Acar, Philippe; Ferrieres, Jean; Jondeau, Guillaume; Dulac, Yves.
Afiliación
  • Hascoet S; Department of Paediatric Cardiology and Paediatric Endocrinology, Centre de Référence pour le Syndrome de Marfan et Apparentés, Hôpital des Enfants, CHU Toulouse, 31300 Toulouse, France; Department of Congenital Heart Diseases, Centre Constitutif Réseau M3C (Maladies Rares Cardiopathies Congénitales
  • Edouard T; Department of Paediatric Cardiology and Paediatric Endocrinology, Centre de Référence pour le Syndrome de Marfan et Apparentés, Hôpital des Enfants, CHU Toulouse, 31300 Toulouse, France.
  • Plaisancie J; Department of Paediatric Cardiology and Paediatric Endocrinology, Centre de Référence pour le Syndrome de Marfan et Apparentés, Hôpital des Enfants, CHU Toulouse, 31300 Toulouse, France.
  • Arnoult F; Department of Cardiology, Centre de Référence pour le Syndrome de Marfan et Apparentés, Hôpital Bichat, AP-HP, 75018 Paris, France.
  • Milleron O; Department of Cardiology, Centre de Référence pour le Syndrome de Marfan et Apparentés, Hôpital Bichat, AP-HP, 75018 Paris, France; Inserm U1148, 75877 Paris, France.
  • Stheneur C; Department of Cardiology, Centre de Référence pour le Syndrome de Marfan et Apparentés, Hôpital Bichat, AP-HP, 75018 Paris, France; Inserm U1148, 75877 Paris, France; Department of Paediatrics, Hôpital Ambroise Paré, AP-HP, 92100 Boulogne-Billancourt, France.
  • Chevallier B; Inserm U1148, 75877 Paris, France.
  • Zordan C; Department of Clinical Genetics, Centre de Compétence pour le Syndrome de Marfan et Apparentés, CHU Bordeaux, 33000 Bordeaux, France.
  • Odent S; Department of Clinical Genetics, Centre de Compétence pour le Syndrome de Marfan et Apparentés, Hôpital Sud CHU, 35200 Rennes, France.
  • Bal L; Department of Clinical Genetics and Aortic Diseases, Centre de Compétence pour le Syndrome de Marfan et Apparentés, Hôpital de la Timone, AP-HM, 13005 Marseille, France.
  • Faivre L; Department of Clinical Genetics, Centre de Compétence pour le Syndrome de Marfan et Apparentés, Hôpital d'enfants, CHU, Université de Bourgogne Franche Comté, 21070 Dijon, France.
  • Leheup B; Department of Clinical Genetics, Centre de Compétence pour le Syndrome de Marfan et Apparentés, Hôpital des Enfants Brabois, CHU Nancy, 54500 Vandoeuvre-lès-Nancy, France.
  • Dupuis-Girod S; Department of Clinical Genetics, Hospices Civils de Lyon, Centre de Compétence pour le Syndrome de Marfan et Apparentés, Hôpital Femme-Mère-Enfants, 69677 Bron, France.
  • Ruidavets JB; Department of Epidemiology, 31073 Toulouse; Inserm/UPS UMR 1048, I2MC, 31432 Toulouse, France; CHU de Toulouse, 31059 Toulouse, France.
  • Acar P; Department of Paediatric Cardiology and Paediatric Endocrinology, Centre de Référence pour le Syndrome de Marfan et Apparentés, Hôpital des Enfants, CHU Toulouse, 31300 Toulouse, France.
  • Ferrieres J; Department of Epidemiology, 31073 Toulouse; Inserm/UPS UMR 1048, I2MC, 31432 Toulouse, France; CHU de Toulouse, 31059 Toulouse, France.
  • Jondeau G; Department of Cardiology, Centre de Référence pour le Syndrome de Marfan et Apparentés, Hôpital Bichat, AP-HP, 75018 Paris, France; Inserm U1148, 75877 Paris, France.
  • Dulac Y; Department of Paediatric Cardiology and Paediatric Endocrinology, Centre de Référence pour le Syndrome de Marfan et Apparentés, Hôpital des Enfants, CHU Toulouse, 31300 Toulouse, France.
Arch Cardiovasc Dis ; 113(1): 40-49, 2020 Jan.
Article en En | MEDLINE | ID: mdl-31735609
BACKGROUND: Little is known about the incidence of cardiovascular events (CVEs) and their associated risk markers in children with Marfan syndrome (MFS). AIMS: To assess the incidence of CVEs and determine risk markers in a cohort diagnosed with Marfan syndrome during childhood and followed for several years. METHODS: From a French multicentre nationwide database, 462 patients with MFS diagnosed during childhood were included prospectively. Patients' files were screened for a period of 20 years (1993-2013). CVEs (e.g. death, aortic dissection, cardiac valve or aortic root surgery) were assessed during the prospective follow-up. RESULTS: Median (interquartile range) age at the end of follow-up was 17.2 (11.1-21.3) years. CVEs were reported for 35 participants (7.6%; 95% confidence interval [CI] 5.3-10.4%). First CVEs were prophylactic aortic root surgery (n=29), aortic dissection (n=4; two aged <18 years) and death (n=2). Kaplan-Meier cumulative incidence of CVEs was 5.3% (95% CI 3.3-8.7%) during childhood (aged≤18 years) and 19.4% (95% CI 13.3-27.9%) at 25years of age. The cumulative rate of CVEs was higher in case of Valsalva sinus Z-score increase of≥0.1 per year (P=0.0003), maximal Valsalva sinus diameter growth speed ≥5mm per year (P=0.03), aortic regurgitation≥2 (P=0.0005) and maximal Valsalva sinus Z-score≥3 before 16 years of age (P<0.0001). In a multivariable Cox proportional analysis, the Valsalva sinus Z-score remained significantly related to outcome. Considering aortic root evolution, aortic regurgitation, age at diagnosis and beta-blocker therapy were related to Valsalva sinus Z-score evolution during follow-up. CONCLUSIONS: CVEs in children with MFS are mainly related to prophylactic aortic root surgery. Aortic dissections are rarely observed in children. The Valsalva sinus Z-score is a strong indicator of subsequent CVEs in children with MFS. Attention to follow-up and beta-blocker observance may be warranted in high-risk children.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Síndrome de Marfan Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male País/Región como asunto: Europa Idioma: En Revista: Arch Cardiovasc Dis Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA Año: 2020 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Síndrome de Marfan Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male País/Región como asunto: Europa Idioma: En Revista: Arch Cardiovasc Dis Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA Año: 2020 Tipo del documento: Article Pais de publicación: Países Bajos